<DOC>
	<DOCNO>NCT01634113</DOCNO>
	<brief_summary>The primary objective trial evaluate safety efficacy two dos tiotropium inhalation solution deliver via Respimat® inhaler daily afternoon patient ( 1 5 year old ) persistent asthma top inhale corticosteroid ( ICS ) treatment .</brief_summary>
	<brief_title>Evaluation Tiotropium 2.5 5 mcg Once Daily Delivered Via Respimat® Inhaler Compared Placebo 1 5 Year Old Patients With Persistent Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Bromides</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<criteria>Inclusion criterion : 1 . All patient ' parent ( legal guardian ) must sign date inform consent consistent ICHGCP guideline local legislation prior participation trial . Where appropriate , participant assent enroll study . 2 . Male female patient 1 5 year age . 3 . By physician document ( least 6 month ) history persistent asthma symptom , include ( limited ) wheezing , cough , and/or shortness breath . ( persistent = need inhalation corticosteroid maintenance therapy control asthma symptom ) 4 . For patient age 5 year capable perform technically acceptable Pulmonary Function test ( PFTs ) : document impaired lung function ( i.e . prebronchodilator Forced Expiratory Volume 1 second ( FEV1 ) small equal 90 % predict normal ) . 5 . All patient must maintenance treatment inhaled corticosteroid stable dose , either mono treatment combination another controller medication , least 4 week Visit 1 . 6 . All patient must symptomatic ( partly control ) define Global Initiative Asthma ( GINA ) guideline child age 5 year young week prior Visit 1 ( screen ) week prior randomisation ( Visit 2 ) . Further inclusion criterion apply . Exclusion criterion : 1 . Patients significant disease asthma . 2 . Patients clinically relevant abnormal screen haematology blood chemistry exclude abnormality defines significant disease define exclusion criterion 1 . 3 . Patients history congenital acquire heart disease , patient hospitalise cardiac syncope failure past year . 4 . Patients unstable lifethreatening cardiac arrhythmia , include cardiac arrhythmia require intervention ( e.g . pacemaker implantation ) change drug therapy within past year . 5 . Patients malignancy patient undergone resection , radiation therapy chemotherapy . 6 . Patients clinically significant lung disease asthma . 7 . Alternative cause ( cause asthma ) lead respiratory symptom wheeze , cough shortness breath . 8 . Patients know active tuberculosis . 9 . Patients undergone thoracotomy pulmonary resection . 10 . Patients currently pulmonary rehabilitation program complete pulmonary rehabilitation program 6 week prior screen visit ( Visit 1 ) . Further exclusion criterion apply .</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>